Kelvin A. Baggett serves as a Senior Managing Director and Head of Patient Impact at Patient Square Capital, a healthcare investment firm. In this role, he also chairs the EMPIRIC Institute, focusing on strategic investments that partner with management teams to improve health through products, services, and technologies. Patient Square Capital targets opportunities across the broad healthcare industry, including biopharmaceuticals, medical devices, and technology-enabled services.